COLADONATO, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 682
EU - Europa 157
AS - Asia 99
OC - Oceania 2
Totale 940
Nazione #
US - Stati Uniti d'America 676
SE - Svezia 54
SG - Singapore 50
CN - Cina 46
IT - Italia 24
RU - Federazione Russa 17
FR - Francia 16
GB - Regno Unito 10
DE - Germania 8
BE - Belgio 7
CA - Canada 6
CZ - Repubblica Ceca 6
FI - Finlandia 6
IE - Irlanda 3
AU - Australia 2
LT - Lituania 2
UA - Ucraina 2
AT - Austria 1
ES - Italia 1
IN - India 1
IR - Iran 1
TR - Turchia 1
Totale 940
Città #
Fairfield 97
Chandler 92
Houston 50
Nyköping 50
Woodbridge 46
Ann Arbor 44
Singapore 38
Cambridge 37
Seattle 36
Ashburn 35
Wilmington 31
Beijing 21
New York 15
Lawrence 14
Roxbury 12
Dearborn 8
Des Moines 8
Jacksonville 8
Brussels 7
Inglewood 7
San Diego 7
Brooklyn 5
Munich 5
Olomouc 5
Princeton 5
Toronto 5
Boardman 4
London 4
Paris 4
Dublin 3
Helsinki 3
Nanjing 3
Shenyang 3
Augusta 2
Bari 2
Florence 2
Guangzhou 2
Hebei 2
Jinan 2
Jinhua 2
Nanchang 2
Saint-Fons 2
San Mateo 2
Santa Clara 2
Washington 2
Ardabil 1
Brindisi 1
Brno 1
Canberra 1
Clifton 1
Grottaglie 1
Indiana 1
Jiaxing 1
Kilburn 1
Kunming 1
Leawood 1
Los Angeles 1
Madrid 1
Melbourne 1
Modugno 1
Mountain View 1
Mumbai 1
Ottawa 1
Redwood City 1
Shenzhen 1
Trani 1
Vienna 1
Zhengzhou 1
Totale 759
Nome #
Evaluation of differences in carotid intima-media thickness in patients affected by systemic rheumatic diseases 108
Paradoxical mucocutaneous flare in a case of Behçet’s disease treated with tocilizumab 98
Splenic Infarction as Only Manifestation of Antiphospholipid Syndrome in a Patient With Rheumatoid Arthritis 82
Early Lupus Project: one-year follow-up of an Italian cohort of patients with systemic lupus erythematosus of recent onset 81
SAT0216 Chest Ultrasound Signs of Interstitial Lung Disease in Systemic Sclerosis Patients: A Comparison between High Resolution Chest Computed Tomography Findings 76
LIPID PROFILE OF RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ANTI-TNF-ALPHA DRUGS CHANGES ACCORDING TO DISEASE ACTIVITY RESPONSE 73
Bone and kidney toxicity induced by nucleotide analogues in patients affected by HBV-related chronic hepatitis: a longitudinal study. 67
OP0129 Drug survival on anti-tnf-alpha in psoriatic arthritis patients with axial involvement and analysis of predictors 63
SAT0380 FIBROMYALGIA IS THE STRONGEST NEGATIVE PREDICTOR FOR THE ACHIEVEMENT OF EITHER REMISSION AND MINIMAL DISEASE ACTIVITY IN NAIVE PSORIATIC ARTHRITIS PATIENTS STARTING BIOLOGIC DRUGS 58
Giant Cell Tumor of Synovial Sheath: Of Two Cases Treated with Intra-Articular Infiltration of Infliximab 52
Improvement of Refractory Dysphagia in Patients with Idiopathic Inflammatory Myopathies Receveing Immunoglobulin Intravenous Therapy 49
Efficacy of baricitinib on refractory skin papulosquamous rash in a patient with systemic lupus erythematosus 47
Severe muscle damage with myofiber necrosis and macrophage infiltrates characterize anti-Mi2 positive dermatomyositis 40
Risk factors of damage in early diagnosed systemic lupus erythematosus: Results of the Italian multicentre Early Lupus Project inception cohort 29
Validity of Machine Learning in Predicting Giant Cell Arteritis Flare After Glucocorticoids Tapering 22
Plasma pentraxin 3 in idiopathic inflammatory myopathies: a possible new biomarker of disease activity 13
Erratum: Efficacy of baricitinib on refractory skin papulosquamous rash in a patient with systemic lupus erythematosus (Rheumatology (2020) 59 (1188) DOI: 10.1093/rheumatology/kez442) 11
Anti-SAE dermatomyositis: clinical and histologic characteristics from a monocentric Italian cohort 8
Clinical, histologic and prognostic features of clinically amyopathic dermatomyositis 6
Effectiveness of Tapering Rituximab Dose in Idiopathic Inflammatory Myopathies: Real-World Data from a Monocentric Study 3
Totale 986
Categoria #
all - tutte 5.547
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.547


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020161 0 0 0 0 0 0 40 31 35 27 15 13
2020/2021114 4 17 3 9 11 7 2 15 12 16 10 8
2021/2022119 4 4 2 6 8 9 8 4 8 9 18 39
2022/2023217 25 38 13 26 16 29 4 24 24 5 6 7
2023/202484 5 23 7 4 5 20 1 1 0 4 5 9
2024/2025107 12 9 23 12 4 47 0 0 0 0 0 0
Totale 986